Each pen holds 4 maintenance doses of either 0.5 mg, 1 mg, or 2 mg of medicine given once weekly and will last for one month
We respond the same week
Eli Lillys tirzepatide (Mounjaro and Zepbound) is a GIP (glucose-dependent insulinotropic polypeptide)/GLP-1 dual agonist that is demonstrating excellent weight loss, type 2 diabetes management, as well as cardiovascular protection
For instance, high pro-inflammatory cytokines in SAM upregulate hepcidin expression, diminishing iron bioavailability and erythropoiesis and precipitating anemia [113]
They found that even without causing weight loss, retatrutide had anti-tumor effects that were similar to the currently used (and incredibly expensive) immunotherapy.[ref] A 5-year mortality study in colon cancer patients showed that GLP-1 RA use decreased mortality risk by 60% in obese patients.[ref] Animal studies may show the mechanism
Pricing: $249/month for semaglutide tablets, $299/month for tirzepatide tablets, $199/month for sublingual semaglutide